So these clever Morgan's assumed 6 months ago that $36m was easy and hence target of 56c...
Now with markets tight , they reduce the target to 0.27 c..when the target was 56c we were really far away with even EMA approval not in place ...
Last 3 years none of these reports have met the targets ...dunno why they bother...and ANP says they want to preserve the capital...then why pay these guys for some BS report...
I also think CR is coming very soon.....Let's get over and done with ....more dilution but what's the choice when you have MD at helm...
Move forward....and let's get this trial running asap and not worry about $$..
Ann: ATL1102 DMD Clinical Trial Application Submitted in Europe, page-38
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
-0.001(1.23%) |
Mkt cap ! $82.94M | |||
| Open | High | Low | Value | Volume |
| 8.0¢ | 8.0¢ | 7.9¢ | $184.6K | 2.329M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300000 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 398428 | 6 |
View Market Depth
| Last trade - 14.44pm 01/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |